Cargando…
Comparison of the epidemiology of invasive pneumococcal disease between Australia and New Zealand in 2017–2021: an observational study based on surveillance data
BACKGROUND: The Australian immunisation schedule uses 13-valent pneumococcal conjugate vaccine (PCV13), while New Zealand (NZ) changed from PCV13 to 10-valent PCV (PCV10) in 2017. In NZ, cases of serotype 19A (not in PCV10) have been increasing since 2017. We compared invasive pneumococcal disease (...
Autores principales: | Hagedoorn, Nienke N., Anglemyer, Andrew, Gilkison, Charlotte, Hartley, Mica, Walls, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398586/ https://www.ncbi.nlm.nih.gov/pubmed/37547043 http://dx.doi.org/10.1016/j.lanwpc.2023.100764 |
Ejemplares similares
-
Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020
por: Tio, Shio Yen, et al.
Publicado: (2023) -
Impact of vaccination on invasive pneumococcal disease in Italy 2007–2017: surveillance challenges and epidemiological changes
por: Monali, R., et al.
Publicado: (2020) -
Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010–2012
por: Lai, Jana YR, et al.
Publicado: (2013) -
Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance
por: Braeye, Toon, et al.
Publicado: (2016) -
The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
por: Wijayasri, Shinthuja, et al.
Publicado: (2019)